Back to Search Start Over

Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies.

Authors :
Bruzzese A
Martino EA
Labanca C
Mendicino F
Lucia E
Olivito V
Neri A
Morabito F
Vigna E
Gentile M
Source :
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Feb; Vol. 33 (2), pp. 73-77. Date of Electronic Publication: 2024 Jan 26.
Publication Year :
2024

Subjects

Subjects :
Humans
Proto-Oncogene Proteins c-bcl-2
Hematologic Neoplasms drug therapy
Hematologic Neoplasms pathology
Antineoplastic Agents pharmacology
Antineoplastic Agents therapeutic use

Details

Language :
English
ISSN :
1744-7658
Volume :
33
Issue :
2
Database :
MEDLINE
Journal :
Expert opinion on investigational drugs
Publication Type :
Editorial & Opinion
Accession number :
38264792
Full Text :
https://doi.org/10.1080/13543784.2024.2309873
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details